Healthcare -
Biotechnology - NASDAQ - US
$ 2.725
0.408 %
$ 174 M
Market Cap
-1.63
P/E
LRMR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities LRMR - Larimar Therapeutics, Inc.
162 M
LAST VALUE
46.67%
2 YEAR CAGR
52.86%
5 YEAR CAGR
4.12%
10 YEAR CAGR